These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34641930)

  • 1. Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.
    D'Amico A; Longo A; Fattori F; Tosi M; Bosco L; Chiarini Testa MB; Paglietti MG; Cherchi C; Carlesi A; Mizzoni I; Bertini E
    Orphanet J Rare Dis; 2021 Oct; 16(1):425. PubMed ID: 34641930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims.
    Sacks NC; Healey BE; Cyr PL; Slocomb T; James E; Beggs AH; Graham RJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1019-1026. PubMed ID: 33843254
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.
    Lawlor MW; Schoser B; Margeta M; Sewry CA; Jones KA; Shieh PB; Kuntz NL; Smith BK; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Blaschek A; Neuhaus S; Foley AR; Saade DN; Tsuchiya E; Qasim UR; Beatka M; Prom MJ; Ott E; Danielson S; Krakau P; Kumar SN; Meng H; Vanden Avond M; Wells C; Gordish-Dressman H; Beggs AH; Christensen S; Conner E; James ES; Lee J; Sadhu C; Miller W; Sepulveda B; Varfaj F; Prasad S; Rico S
    EBioMedicine; 2024 Jan; 99():104894. PubMed ID: 38086156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an MTM1-mutant iPSC line (CRICKi008-A) from an individual with X-linked myotubular myopathy (XLMTM).
    Devito LG; Lionello VM; Muntoni F; Tedesco FS; Healy L
    Stem Cell Res; 2023 Jun; 69():103079. PubMed ID: 36989620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States.
    Graham RJ; Darras BT; Haselkorn T; Fisher D; Genetti CA; Miller W; Beggs AH
    Orphanet J Rare Dis; 2023 Jun; 18(1):138. PubMed ID: 37280644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report.
    Molera C; Sarishvili T; Nascimento A; Rtskhiladze I; Muñoz Bartolo G; Fernández Cebrián S; Valverde Fernández J; Muñoz Cabello B; Graham RJ; Miller W; Sepulveda B; Kamath BM; Meng H; Lawlor MW
    J Neuromuscul Dis; 2022; 9(1):73-82. PubMed ID: 34366366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Genotype-Phenotype Correlations in X-Linked Myotubular Myopathy and the Use of the Face2Gene Application as an Effective Non-Invasive Diagnostic Tool.
    Kušíková K; Šoltýsová A; Ficek A; Feichtinger RG; Mayr JA; Škopková M; Gašperíková D; Kolníková M; Ornig K; Kalev O; Weis S; Weis D
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmias in patients with X-linked myotubular myopathy.
    Pons-Espinal M; Clotet-Caba J; Cesar-Díaz S; Yubero-Siles D
    Rev Neurol; 2023 Aug; 77(3):79-81. PubMed ID: 37466134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked myotubular myopathy mimics hereditary spastic paraplegia in two female manifesting carriers of pathogenic MTM1 variant.
    Kraatari M; Tuominen H; Tuupanen S; Haapaniemi T; Moilanen J; Rahikkala E
    Eur J Med Genet; 2020 Nov; 63(11):104040. PubMed ID: 32805447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
    Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
    Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy.
    Bryen SJ; Oates EC; Evesson FJ; Lu JK; Waddell LB; Joshi H; Ryan MM; Cummings BB; McLean CA; MacArthur DG; Kornberg AJ; Cooper ST
    Eur J Hum Genet; 2021 Jan; 29(1):61-66. PubMed ID: 32862205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons.
    Lawlor MW; Beggs AH; Buj-Bello A; Childers MK; Dowling JJ; James ES; Meng H; Moore SA; Prasad S; Schoser B; Sewry CA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):102-10. PubMed ID: 26823526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
    Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
    Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy.
    Karolczak S; Deshwar AR; Aristegui E; Kamath BM; Lawlor MW; Andreoletti G; Volpatti J; Ellis JL; Yin C; Dowling JJ
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37490339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy.
    Dowling JJ; Müller-Felber W; Smith BK; Bönnemann CG; Kuntz NL; Muntoni F; Servais L; Alfano LN; Beggs AH; Bilder DA; Blaschek A; Duong T; Graham RJ; Jain M; Lawlor MW; Lee J; Coats J; Lilien C; Lowes LP; MacBean V; Neuhaus S; Noursalehi M; Pitts T; Finlay C; Christensen S; Rafferty G; Seferian AM; Tsuchiya E; James ES; Miller W; Sepulveda B; Vila MC; Prasad S; Rico S; Shieh PB;
    J Neuromuscul Dis; 2022; 9(4):503-516. PubMed ID: 35694931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analyses in X-linked myotubular myopathy.
    Noguchi S; Fujita M; Murayama K; Kurokawa R; Nishino I
    Neurology; 2005 Sep; 65(5):732-7. PubMed ID: 16157907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Linked Myotubular Myopathy: A Novel Mutation Expanding the Genotypic Spectrum of a Phenotypically Heterogeneous Myopathy.
    Carvalho A; Costa C; Pinto M; Taipa R; Gonçalves A; Oliveira ME; Ferreira S; Ribeiro JA
    J Pediatr Genet; 2023 Sep; 12(3):258-262. PubMed ID: 37575650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel MTM1 pathogenic variants identified in Japanese patients with X-linked myotubular myopathy.
    Nishikawa A; Iida A; Hayashi S; Okubo M; Oya Y; Yamanaka G; Takahashi I; Nonaka I; Noguchi S; Nishino I
    Mol Genet Genomic Med; 2019 May; 7(5):e621. PubMed ID: 30884204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System.
    Souza PVS; Haselkorn T; Baima J; Oliveira RW; Hernández F; Birck MG; França MC
    Orphanet J Rare Dis; 2024 May; 19(1):188. PubMed ID: 38715109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-Linked Myotubular Myopathy and Mitochondrial Function in Muscle and Liver Samples.
    Inoue K; Kato T; Terasaki E; Ishihara M; Fujii T; Aida Y; Murayama K
    Neuropediatrics; 2024 Jul; ():. PubMed ID: 39008988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.